{"id":406502,"date":"2025-09-28T22:10:24","date_gmt":"2025-09-28T16:40:24","guid":{"rendered":"https:\/\/dripp.zone\/news\/why-elon-musk-sam-altman-and-other-billionaires-are-betting-on-brain-computer-interfaces-crypto-news\/"},"modified":"2025-09-28T22:18:47","modified_gmt":"2025-09-28T16:48:47","slug":"why-elon-musk-sam-altman-and-other-billionaires-are-betting-on-brain-computer-interfaces-crypto-news","status":"publish","type":"post","link":"https:\/\/dripp.zone\/news\/why-elon-musk-sam-altman-and-other-billionaires-are-betting-on-brain-computer-interfaces-crypto-news\/","title":{"rendered":"Why Elon Musk, Sam Altman and Other Billionaires Are Betting On Brain-Computer Interfaces &#8211; Crypto News"},"content":{"rendered":"<div style=\"position:relative;overflow:visible;font-size:1.2em;line-height:1.58\">\n<div class=\"pt-8 pb-10 border-t border-b border-decryptGridline \">\n<h4 class=\"sc-b2a202e4-4 bNRGqr gg-dark:text-white\" color=\"#333\">In brief<\/h4>\n<ul>\n<li class=\"font-meta-serif-pro font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Elon Musk\u2019s Neuralink and the Sam Altman-backed Merge Labs are driving a new wave of billionaire-backed brain-computer interface ventures.<\/li>\n<li class=\"font-meta-serif-pro font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Current BCI progress remains medical, with only five Neuralink patients implanted as of September 2025.<\/li>\n<li class=\"font-meta-serif-pro font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Experts warn BCIs are far from \u201cthought reading,\u201d and billionaire ambitions risk overshadowing real therapeutic potential.<\/li>\n<\/ul>\n<\/div>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Elon Musk already has rockets, cars, AI, and humanoid robots. Musk\u2019s rival Sam Altman runs OpenAI, the company behind the leading AI chatbot, ChatGPT. Now, both men and other billionaires want a piece of the human brain.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Their latest bets on brain-computer interfaces, or BCIs, reveal less about today\u2019s medical breakthroughs and more about a looming contest over who owns the neural on-ramp to digital life. As founders and experts in the space told <i>Decrypt<\/i>, billionaire attention \u201celevates the whole industry\u201d even as it distorts priorities.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">For billionaires, brain-computer interfaces are not just medical devices\u2014they represent the next potential platform shift, a way to control the gateway between human thought and digital systems.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Owning that interface could mean owning the future of computing. That is why some of the most powerful people in the world are pouring money into BCIs: They see them as a hedge against artificial intelligence, a new control point in the tech stack, and perhaps the ultimate frontier for profit and influence.<\/p>\n<h2 class=\"sc-b2a202e4-2 bmropA gg-dark:text-white scene:font-itc-avant-garde-gothic-pro scene:font-light\" style=\"margin-top:2em;text-align:left;padding-bottom:16px;margin-bottom:16px;border-bottom:1px solid #dfe2e4\" color=\"#333\">Musk and Altman make moves<\/h2>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Musk founded Neuralink in 2016 with the <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/www.nbcnews.com\/mach\/tech\/elon-musk-wants-hook-your-brain-directly-computers-starting-next-ncna1030631\" target=\"_blank\" rel=\"noopener\" class=\"sc-adb616fe-0 bJsyml\">goal<\/a> of merging with machines, which he claimed may be the only way to keep pace with artificial intelligence. The company recently raised a <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/neuralink.com\/updates\/neuralink-raises-650m-series-e\/\" target=\"_blank\" rel=\"noopener nofollow external\" class=\"sc-adb616fe-0 bJsyml\">$650 million<\/a> Series E, placing it among the best-funded players in the field. Neuralink\u2019s first patient, Noland Arbaugh, has shown he can control a cursor and browse the internet by thought alone.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">The results have been <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/decrypt.co\/230021\/neuralink-implant-patient-gaming-sets-bci-record\" target=\"_blank\" rel=\"noopener\" class=\"sc-adb616fe-0 bJsyml\">mixed<\/a>, but so far, five patients have now been implanted, with trials expanding to speech impairment and <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/neuralink.com\/updates\/neuralink-receives-breakthrough-device-designation-for-blindsight\/\" target=\"_blank\" rel=\"noopener nofollow external\" class=\"sc-adb616fe-0 bJsyml\">vision<\/a> restoration. Musk keeps framing BCIs as not just medical devices, but a <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/www.forbes.com\/sites\/roberthart\/2023\/09\/21\/elon-musk-says-neuralink-could-slash-risk-from-ai-as-firm-prepares-for-first-human-trials\/\" target=\"_blank\" rel=\"noopener\" class=\"sc-adb616fe-0 bJsyml\">safeguard<\/a> for humanity in an AI-dominated future.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Meanwhile, Altman has <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/www.theverge.com\/news\/758577\/sam-altman-merge-labs-neuralink-rival\" target=\"_blank\" rel=\"noopener\" class=\"sc-adb616fe-0 bJsyml\">surfaced<\/a> as a co-founder of Merge Labs, a new venture aiming to raise around $250 million at a valuation that could reach $850 million. Early reports suggest Merge may pursue non-invasive interfaces, a different path than Neuralink\u2019s brain implants.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">For Altman, who already commands one of the most powerful AI companies, the move signals that the next battle is not only about who builds the smartest models but who controls the pipeline that connects them to humans.<\/p>\n<h2 class=\"sc-b2a202e4-2 bmropA gg-dark:text-white scene:font-itc-avant-garde-gothic-pro scene:font-light\" style=\"margin-top:2em;text-align:left;padding-bottom:16px;margin-bottom:16px;border-bottom:1px solid #dfe2e4\" color=\"#333\">Other major bets<\/h2>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">The circle extends beyond Musk and Altman. Prominent biohacker <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/decrypt.co\/322796\/bryan-johnson-sleep-new-alpha-better-bitcoin-trader\" target=\"_blank\" rel=\"noopener\" class=\"sc-adb616fe-0 bJsyml\">Bryan Johnson<\/a>, who made his fortune in payments, poured <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/www.technologyreview.com\/2017\/03\/16\/153211\/the-entrepreneur-with-the-100-million-plan-to-link-brains-to-computers\/\" target=\"_blank\" rel=\"noopener\" class=\"sc-adb616fe-0 bJsyml\">$100 million<\/a> into Kernel in 2016. Kernel develops neurotech platforms for measuring brain activity, positioning itself as an infrastructure play rather than a flashy implant company.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Neuralink\u2019s investors also include Peter Thiel\u2019s Founders Fund, evidence that Silicon Valley\u2019s venture elite is preparing for the possibility that brain-computer links become the next foundational layer of computing.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">\u201cFor me, their involvement is a good sign,\u201d Tetiana Aleksandrova, CEO and co-founder of neurotechnology startup Subsense, told <i>Decrypt.<\/i> \u201cWhen billionaires step into BCI, they bring visibility and capital that elevate the whole industry. Suddenly, more funds are planning to allocate resources to neurotechnology, more companies are founded, and more engineers discover that this is an exciting space worth dedicating their careers to.\u201d<\/p>\n<p><iframe loading=\"lazy\" style=\"border:0\" src=\"https:\/\/myriad.markets\/embed\/market\/will-tesla-launch-a-driverless-robotaxi-service-in-california-before-mid-december\" width=\"100%\" height=\"415px\"><span data-mce-type=\"bookmark\" style=\"width:0px;overflow:hidden;line-height:0\" class=\"mce_SELRES_start\">\ufeff<\/span><\/iframe><\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">But Aleksandrova cautioned that billionaire involvement cuts both ways.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">\u201cTheir funding can accelerate progress at a pace public funding rarely allows,\u201d she explained. \u201cAt the same time, the pressure to deliver at startup speed can lead to unrealistic promises that put trust at risk. And in science, trust is just as critical as capital.\u201d<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Andreas Melhede, co-founder of neuroscience DAO Elata Bioscience, told <i>Decrypt<\/i> that while billionaire involvement accelerates interest and funding, it also narrows the agenda.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">\u201cThe priorities tend to reflect the vision of a single individual or a gatekept corporate agenda, rather than the broader scientific community,\u201d he said. \u201cThat means research often skews toward &#8216;moonshot&#8217; projects designed to capture attention, rather than significant collaborative advances that actually move the field forward.\u201d<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Melhede agreed that billionaire rhetoric can both be good for and do harm to the industry, risking overshadowing important but less glamorous work. The bigger risk, he said, is centralization of power over something as important as human brains.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">\u201cIf one company owns the infrastructure, code, and data, they own the keys to an individual\u2019s thoughts and intentions,\u201d he said. \u201cThis discourages transparency [and] slows independent validation and scientific progress. Access to BCI technology\u2014and cognitive autonomy\u2014is subject to the business decisions of a handful of high-profile figures. That is too much risk in too few hands.\u201d<\/p>\n<h2 class=\"sc-b2a202e4-2 bmropA gg-dark:text-white scene:font-itc-avant-garde-gothic-pro scene:font-light\" style=\"margin-top:2em;text-align:left;padding-bottom:16px;margin-bottom:16px;border-bottom:1px solid #dfe2e4\" color=\"#333\">Speculation vs. reality<\/h2>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">That tension defines the field. The billionaire pitch is sweeping\u2014control the neural interface, control the future. But the present reality is narrower: coarse signals, fragile hardware, and systems that cannot \u201cread thoughts\u201d in the way public rhetoric sometimes suggests.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Still, such a breakthrough could occur \u201cconceivably some day,\u201d Gary Marcus, a cognitive scientist and professor <i>emeritus<\/i> of psychology and neural science at New York University, told <i>Decrypt<\/i>. \u201cFor now, we just don\u2019t understand the neural code well enough. Of course, there are already interventions that make sense for people who are paralyzed and with few other options.\u201d<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">Companies like Synchron and Inbrain continue pilot trials, with Inbrain\u2019s graphene-based BCI platform receiving FDA Breakthrough Device designation. But these remain early-stage efforts, far from mass-market enhancement.<\/p>\n<h2 class=\"sc-b2a202e4-2 bmropA gg-dark:text-white scene:font-itc-avant-garde-gothic-pro scene:font-light\" style=\"margin-top:2em;text-align:left;padding-bottom:16px;margin-bottom:16px;border-bottom:1px solid #dfe2e4\" color=\"#333\">The stakes<\/h2>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">The question is less whether brain-computer interfaces will work at scale, and more whose vision defines them. Musk frames BCIs as an existential safeguard. Altman positions them as strategic control points. Johnson and Thiel treat them as infrastructure bets.<\/p>\n<p class=\"font-meta-serif-pro scene:font-noto-sans scene:text-base scene:md:text-lg font-normal text-lg md:text-xl md:leading-9 tracking-px text-body gg-dark:text-neutral-100\">For patients, the technology is about restoring lost abilities. For billionaires, it is about shaping the next human-machine platform\u2014one where whoever owns the gateway may one day set the rules for how thought itself becomes data.<\/p>\n<div class=\"my-4 border-b border-decryptGridline\">\n<div class=\"text-start p-8 md:py-12 md:px-12 max-w-prose relative\"><span class=\"border-t-4 border-l-4 w-4 h-4 md:border-t-[6px] md:border-l-[6px] md:w-6 md:h-6 border-decryptPurple dark:border-decryptNeon gg-dark:border-cc-pink-2 absolute top-4 left-4 md:top-6 md:left-6\"\/><span class=\"border-t-4 border-l-4 w-4 h-4 md:border-t-[6px] md:border-l-[6px] md:w-6 md:h-6 border-decryptPurple dark:border-decryptNeon gg-dark:border-cc-pink-2 absolute rotate-180 bottom-4 right-4 md:bottom-6 md:right-6\"\/><\/p>\n<h3 class=\"font-akzidenz-grotesk font-bold text-xl md:text-3xl md:text-center gg-dark:text-white\">Generally Intelligent<!-- --> Newsletter<\/h3>\n<p>A weekly AI journey narrated by Gen, a generative AI model.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In brief Elon Musk\u2019s Neuralink and the Sam Altman-backed Merge Labs are driving a new wave of billionaire-backed brain-computer interface ventures. Current BCI progress remains medical, with only five Neuralink patients implanted as of September 2025. Experts warn BCIs are far from \u201cthought reading,\u201d and billionaire ambitions risk overshadowing real therapeutic potential. Elon Musk already [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":406504,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[230,225,221,227,226,228,229,60,223,224,222],"class_list":["post-406502","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cryptocurrency","tag-brave","tag-coinbase","tag-crypto","tag-decentralised","tag-decentralized","tag-decentralized-exchange","tag-erc-20","tag-featured","tag-meme-coin","tag-robinhood","tag-solana"],"_links":{"self":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/406502","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/comments?post=406502"}],"version-history":[{"count":1,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/406502\/revisions"}],"predecessor-version":[{"id":406505,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/posts\/406502\/revisions\/406505"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/media\/406504"}],"wp:attachment":[{"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/media?parent=406502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/categories?post=406502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dripp.zone\/news\/wp-json\/wp\/v2\/tags?post=406502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}